Search Press releases Keywords From To 23 Jan 2009 UCB to divest selected smaller markets to further focus on its key strategic areas Read More 9 Jan 2009 UCB and WILEX to enter into strategic alliance to develop UCB's preclinical oncology portfolio Read More 5 Jan 2009 UCB receives Complete Response Letter from U.S. FDA for use of Cimzia® in rheumatoid arthritis patients Read More 19 Dec 2008 UCB receives U.S. FDA Complete Response Letter for Neupro® in Restless Legs Syndrome and Advanced Parkinson's disease Read More 2 Dec 2008 UCB announces start of Phase I study for antibody drug candidate CDP6038 Read More 20 Nov 2008 Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate in Fibromyalgia Read More Pagination First page Previous page Previous … Page 168 Page 169 Page 170 Page 171 Current page 172 Page 173 Page 174 Page 175 Page 176 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
